Base de dados : MEDLINE
Pesquisa : C14.907.355.830.925.885 [Categoria DeCS]
Referências encontradas : 296 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 30 ir para página                         

  1 / 296 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28459919
[Au] Autor:Noyes AM; Dickey J
[Ad] Endereço:Department of Medicine, Division of Cardiology, Warren Alpert Medical School of Brown University, Providence, RI.
[Ti] Título:The Arm is Not the Leg: Pathophysiology, Diagnosis, and Management of Upper Extremity Deep Vein Thrombosis.
[So] Source:R I Med J (2013);100(5):33-36, 2017 May 01.
[Is] ISSN:2327-2228
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Upper extremity deep venous thrombosis (UEDVT) involves thrombosis of the deep veins of the arm as they enter the thorax. They are increasing in frequency, largely due to the rising use of central venous catheters and implantable cardiac devices, and represent more than 10% of all DVT cases, Upper extremity deep venous thrombosis has been historically misunderstood when compared to lower extremity deep vein thrombosis (LEDVT). Their associated disease states may carry devastating complications, with mortality rates often higher than that of LEDVT. Thus, education on recognition, classification and management is critical to avoid long-term sequelae and mortality from UEDVT. [Full article available at http://rimed.org/rimedicaljournal-2017-05.asp].
[Mh] Termos MeSH primário: Trombose Venosa Profunda de Membros Superiores/diagnóstico
Trombose Venosa Profunda de Membros Superiores/terapia
[Mh] Termos MeSH secundário: Seres Humanos
Trombose Venosa Profunda de Membros Superiores/fisiopatologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180221
[Lr] Data última revisão:
180221
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170502
[St] Status:MEDLINE


  2 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390472
[Au] Autor:Wang K; Sun W; Shi X
[Ad] Endereço:Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
[Ti] Título:Upper extremity deep vein thrombosis after migration of peripherally inserted central catheter (PICC): A case report.
[So] Source:Medicine (Baltimore);96(51):e9222, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Peripherally inserted central venous catheters (PICC) are widely used in cancer patients and ultrasound-guided PICC insertion could improve success rate. The tip position of the catheter should be located at the border of lower one-third of the superior vena cava (SVC) and cavo-atrial junction. The migration is malposition at the late stage after PICCs were inserted, and catheter malposition was associated with thrombosis and other complications.After patient's informed consent, we report a case of a 66-year-old male with twice catheter migrations resulting in thrombosis after being diagnosed with cardiac cancer. CONCLUSION: The correct position of the catheter tip can ensure the normal use of PICC and reduce the complications. For the migrated catheter, it should be removed as soon as possible, and when thrombosis has been developed, standard anticoagulant therapy should be given.
[Mh] Termos MeSH primário: Anticoagulantes/administração & dosagem
Cateterismo Periférico/efeitos adversos
Cateteres Venosos Centrais/efeitos adversos
Migração de Corpo Estranho/complicações
Trombose Venosa Profunda de Membros Superiores/etiologia
Trombose Venosa Profunda de Membros Superiores/terapia
[Mh] Termos MeSH secundário: Idoso
Cateterismo Periférico/métodos
Remoção de Dispositivo
Falha de Equipamento
Seguimentos
Migração de Corpo Estranho/diagnóstico por imagem
Neoplasias Cardíacas/diagnóstico
Neoplasias Cardíacas/tratamento farmacológico
Seres Humanos
Masculino
Medição de Risco
Resultado do Tratamento
Ultrassonografia Doppler em Cores/métodos
Trombose Venosa Profunda de Membros Superiores/diagnóstico por imagem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anticoagulants)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009222


  3 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29388461
[Au] Autor:Samoila G; Twine CP; Williams IM
[Ad] Endereço:Cardiff and Vale University Health Board , UK.
[Ti] Título:The infraclavicular approach for Paget-Schroetter syndrome.
[So] Source:Ann R Coll Surg Engl;100(2):83-91, 2018 Feb.
[Is] ISSN:1478-7083
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Introduction Paget-Schroetter syndrome is a rare effort thrombosis of the axillary-subclavian vein, mainly occurring in young male patients. Current management involves immediate catheter directed thrombolysis, followed by surgical decompression of the subclavian vein. This has been invariably performed using a transaxillary or supraclavicular approach. However, the subclavian vein crosses the first rib anteriorly just behind the manubrium and can also be accessed via an infraclavicular incision. Methods MEDLINE and Embase™ were searched for all studies on outcomes in patients undergoing infraclavicular first rib resection for treatment of Paget-Schroetter syndrome. Measured outcomes included freedom from reintervention, secondary patency and symptom resolution. Studies on neurogenic, arterial and iatrogenic venous thoracic outlet syndrome were not included. Findings Six studies (involving 268 patients) were eligible. The overall secondary venous patency rate was 98.5%. There was freedom from reintervention in 89.9% of cases and among those patients with reocclusion, 84.0% had chronic thrombosis (symptom duration >14 days), with 76.2% having a venous segment stenosis of >2cm. Only 3 of the 27 patients remained occluded despite reintervention. The infraclavicular approach provides excellent exposure to the subclavian vein and allows reconstruction when required. Moreover, this approach enables complete resection of the extrinsic compression that precipitated the initial thrombotic event, with excellent long-term patency rates. In conclusion, the infraclavicular route may have significant advantages compared with the transaxillary or supraclavicular approaches for successful and durable treatment of Paget-Schroetter syndrome.
[Mh] Termos MeSH primário: Descompressão Cirúrgica/métodos
Veia Subclávia/cirurgia
Trombose Venosa Profunda de Membros Superiores/cirurgia
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Masculino
Síndrome do Desfiladeiro Torácico/cirurgia
Terapia Trombolítica/métodos
Trombose Venosa Profunda de Membros Superiores/diagnóstico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180209
[Lr] Data última revisão:
180209
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180202
[St] Status:MEDLINE
[do] DOI:10.1308/rcsann.2017.0154


  4 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
[PMID]:29226949
[Au] Autor:Feinberg J; Nielsen EE; Jakobsen JC
[Ad] Endereço:Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark, 2100.
[Ti] Título:Thrombolysis for acute upper extremity deep vein thrombosis.
[So] Source:Cochrane Database Syst Rev;12:CD012175, 2017 12 11.
[Is] ISSN:1469-493X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: About 5% to 10% of all deep vein thromboses occur in the upper extremities. Serious complications of upper extremity deep vein thrombosis, such as post-thrombotic syndrome and pulmonary embolism, may in theory be avoided using thrombolysis. No systematic review has assessed the effects of thrombolysis for the treatment of individuals with acute upper extremity deep vein thrombosis. OBJECTIVES: To assess the beneficial and harmful effects of thrombolysis for the treatment of individuals with acute upper extremity deep vein thrombosis. SEARCH METHODS: The Cochrane Vascular Information Specialist (CIS) searched the Specialised Register (29 March 2017), the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2), and three trial registries (World Health Organization International Clinical Trials Registry, ClinicalTrials.gov, and ISRCTN registry) for ongoing and unpublished studies. We additionally searched the registries of the European Medical Agency and the US Food and Drug Administration (December 2016). SELECTION CRITERIA: We planned to include randomised clinical trials irrespective of publication type, publication date and language that investigated the effects of thrombolytics added to anticoagulation, thrombolysis versus anticoagulation, or thrombolysis versus any other type of medical intervention for the treatment of acute upper extremity deep vein thrombosis. DATA COLLECTION AND ANALYSIS: Two review authors independently screened all records to identify those that met inclusion criteria. We planned to use the standard methodological procedures expected by Cochrane. We planned to use trial domains to assess the risks of systematic error (bias) in the trials. We planned to conduct trial sequential analyses to control for the risk of random errors and to assess the robustness of our conclusions. We planned to consider a P value of 0.025 or less as statistically significant. We planned to assess the quality of the evidence using the GRADE approach. Our primary outcomes were severe bleeding, pulmonary embolism, and all-cause mortality. MAIN RESULTS: We found no trials eligible for inclusion. We also identified no ongoing trials. AUTHORS' CONCLUSIONS: There is currently insufficient evidence from which to draw conclusion on the benefits or harms of thrombolysis for the treatment of individuals with acute upper extremity deep vein thrombosis as an add-on therapy to anticoagulation, alone compared with anticoagulation, or alone compared with any other type of medical intervention. Large randomised clinical trials with a low risk of bias are warranted. They should focus on clinical outcomes and not solely on surrogate measures.
[Mh] Termos MeSH primário: Terapia Trombolítica/métodos
Trombose Venosa Profunda de Membros Superiores/tratamento farmacológico
[Mh] Termos MeSH secundário: Doença Aguda
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180123
[Lr] Data última revisão:
180123
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171212
[St] Status:MEDLINE
[do] DOI:10.1002/14651858.CD012175.pub2


  5 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28701678
[Au] Autor:Yagi S; Mitsugi M; Sangawa T; Akaike M; Sata M
[Ad] Endereço:Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences.
[Ti] Título:Paget-Schroetter Syndrome in a Baseball Pitcher.
[So] Source:Int Heart J;58(4):637-640, 2017 Aug 03.
[Is] ISSN:1349-3299
[Cp] País de publicação:Japan
[La] Idioma:eng
[Ab] Resumo:Paget-Schroetter syndrome (PSS) is thrombosis of the deep veins draining the upper extremity due to anatomic abnormalities of the thoracic outlet that cause subclavian compression and subsequent thrombosis, leading to thrombus formation in the subclavian vein. Vigorous arm activity in sports is a known risk factor. Here, we report a case of Paget-Schroetter syndrome in a 31-year-old male non-professional baseball pitcher.
[Mh] Termos MeSH primário: Beisebol
Fibrinolíticos/uso terapêutico
Terapia Trombolítica/métodos
Trombose Venosa Profunda de Membros Superiores/diagnóstico
[Mh] Termos MeSH secundário: Adulto
Seres Humanos
Masculino
Tomografia Computadorizada por Raios X
Trombose Venosa Profunda de Membros Superiores/tratamento farmacológico
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Fibrinolytic Agents)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170810
[Lr] Data última revisão:
170810
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170714
[St] Status:MEDLINE
[do] DOI:10.1536/ihj.16-447


  6 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28535970
[Au] Autor:Tabatabaie O; Kasumova GG; Kent TS; Eskander MF; Fadayomi AB; Ng SC; Critchlow JF; Tawa NE; Tseng JF
[Ad] Endereço:Surgical Outcomes Analysis & Research, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
[Ti] Título:Upper extremity deep venous thrombosis after port insertion: What are the risk factors?
[So] Source:Surgery;162(2):437-444, 2017 Aug.
[Is] ISSN:1532-7361
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Totally implantable venous access devices (ports) are widely used, especially for cancer chemotherapy. Although their use has been associated with upper extremity deep venous thrombosis, the risk factors of upper extremity deep venous thrombosis in patients with a port are not studied adequately. METHODS: The Healthcare Cost and Utilization Project's Florida State Ambulatory Surgery and Services Database was queried between 2007 and 2011 for patients who underwent outpatient port insertion, identified by Current Procedural Terminology code. Patients were followed in the State Ambulatory Surgery and Services Database, State Inpatient Database, and State Emergency Department Database for upper extremity deep venous thrombosis occurrence. The cohort was divided into a test cohort and a validation cohort based on the year of port placement. A multivariable logistic regression model was developed to identify risk factors for upper extremity deep venous thrombosis in patients with a port. The model then was tested on the validation cohort. RESULTS: Of the 51,049 patients in the derivation cohort, 926 (1.81%) developed an upper extremity deep venous thrombosis. On multivariate analysis, independently significant predictors of upper extremity deep venous thrombosis included age <65 years (odds ratio = 1.22), Elixhauser score of 1 to 2 compared with zero (odds ratio = 1.17), end-stage renal disease (versus no kidney disease; odds ratio = 2.63), history of any deep venous thrombosis (odds ratio = 1.77), all-cause 30-day revisit (odds ratio = 2.36), African American race (versus white; odds ratio = 1.86), and other nonwhite races (odds ratio = 1.35). Additionally, compared with genitourinary malignancies, patients with gastrointestinal (odds ratio = 1.55), metastatic (odds ratio = 1.76), and lung cancers (odds ratio = 1.68) had greater risks of developing an upper extremity deep venous thrombosis. CONCLUSION: This study identified major risk factors of upper extremity deep venous thrombosis. Further studies are needed to evaluate the appropriateness of thromboprophylaxis in patients at greater risk of upper extremity deep venous thrombosis.
[Mh] Termos MeSH primário: Antineoplásicos/administração & dosagem
Bombas de Infusão Implantáveis/efeitos adversos
Neoplasias/tratamento farmacológico
Trombose Venosa Profunda de Membros Superiores/etiologia
Dispositivos de Acesso Vascular/efeitos adversos
[Mh] Termos MeSH secundário: Idoso
Feminino
Florida
Seres Humanos
Modelos Logísticos
Masculino
Meia-Idade
Neoplasias/complicações
Neoplasias/patologia
Estudos Retrospectivos
Fatores de Risco
Trombose Venosa Profunda de Membros Superiores/diagnóstico
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antineoplastic Agents)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170911
[Lr] Data última revisão:
170911
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170525
[St] Status:MEDLINE


  7 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28373261
[Au] Autor:Rajasekhar A; Streiff MB
[Ad] Endereço:Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL; and.
[Ti] Título:How I treat central venous access device-related upper extremity deep vein thrombosis.
[So] Source:Blood;129(20):2727-2736, 2017 May 18.
[Is] ISSN:1528-0020
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Central venous access device (CVAD)-related thrombosis (CRT) is a common complication among patients requiring central venous access as part of their medical care. Complications of CRT include pulmonary embolism, recurrent deep venous thrombosis, loss of central venous access, and postthrombotic syndrome. Patient-, device-, and treatment-related factors can influence the risk of CRT. Despite numerous randomized controlled trials, the clinical benefit of pharmacologic thromboprophylaxis for the prevention of CRT remains to be established. Therefore, minimizing patient exposure to known risk factors is the best available approach to prevent CRT. Venous duplex is recommended for the diagnosis of CRT. Anticoagulation for at least 3 months or the duration of the indwelling CVAD is recommended for treatment of CRT. Thrombolysis should be considered for patients at low risk for bleeding who have limb-threatening thrombosis or whose symptoms fail to resolve with adequate anticoagulation. CVAD removal should be consider for patients with bacteremia, persistent symptoms despite anticoagulation, and if the CVAD is no longer needed. Superior vena cava filters should be avoided. Prospective studies are needed to define the optimal management of patients with or at risk for CRT.
[Mh] Termos MeSH primário: Cateteres Venosos Centrais/efeitos adversos
Trombose Venosa Profunda de Membros Superiores/etiologia
Trombose Venosa Profunda de Membros Superiores/terapia
[Mh] Termos MeSH secundário: Adulto
Anticoagulantes/uso terapêutico
Remoção de Dispositivo
Feminino
Seres Humanos
Masculino
Meia-Idade
Fatores de Risco
Trombose Venosa Profunda de Membros Superiores/fisiopatologia
Trombose Venosa Profunda de Membros Superiores/prevenção & controle
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anticoagulants)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170911
[Lr] Data última revisão:
170911
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170405
[St] Status:MEDLINE
[do] DOI:10.1182/blood-2016-08-693671


  8 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28330436
[Au] Autor:White JM; Comerota AJ
[Ad] Endereço:1 The Department of Surgery, Walter Reed National Military Medical Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
[Ti] Título:Venous Compression Syndromes.
[So] Source:Vasc Endovascular Surg;51(3):155-168, 2017 Apr.
[Is] ISSN:1938-9116
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Venous compression syndromes occur due to extrinsic compression causing complications of venous hypertension or venous thrombosis. This review focuses on 4 venous compression syndromes involving the left common iliac vein, subclavian vein, left renal vein, and popliteal vein. Clinical presentation, diagnostic methods, and management options are reviewed. When properly diagnosed and treated, long-term consequences can be avoided.
[Mh] Termos MeSH primário: Síndrome de May-Thurner
Doenças Vasculares Periféricas
Veia Poplítea
Síndrome do Quebra-Nozes
Trombose Venosa Profunda de Membros Superiores
[Mh] Termos MeSH secundário: Angiografia por Tomografia Computadorizada
Constrição Patológica
Seres Humanos
Síndrome de May-Thurner/diagnóstico por imagem
Síndrome de May-Thurner/etiologia
Síndrome de May-Thurner/fisiopatologia
Síndrome de May-Thurner/terapia
Doenças Vasculares Periféricas/diagnóstico por imagem
Doenças Vasculares Periféricas/etiologia
Doenças Vasculares Periféricas/fisiopatologia
Doenças Vasculares Periféricas/terapia
Flebografia/métodos
Veia Poplítea/diagnóstico por imagem
Veia Poplítea/fisiopatologia
Síndrome do Quebra-Nozes/diagnóstico por imagem
Síndrome do Quebra-Nozes/etiologia
Síndrome do Quebra-Nozes/fisiopatologia
Síndrome do Quebra-Nozes/terapia
Resultado do Tratamento
Ultrassonografia de Intervenção
Trombose Venosa Profunda de Membros Superiores/diagnóstico por imagem
Trombose Venosa Profunda de Membros Superiores/etiologia
Trombose Venosa Profunda de Membros Superiores/fisiopatologia
Trombose Venosa Profunda de Membros Superiores/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170731
[Lr] Data última revisão:
170731
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170324
[St] Status:MEDLINE
[do] DOI:10.1177/1538574417697208


  9 / 296 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28279410
[Au] Autor:Friedman T; Lopez EE; Quencer KB
[Ad] Endereço:Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical College, New York, NY. Electronic address: TAF9043@med.cornell.edu.
[Ti] Título:Complications in Percutaneous Dialysis Interventions: How to Avoid Them, and How to Treat Them When They do Occur.
[So] Source:Tech Vasc Interv Radiol;20(1):58-64, 2017 Mar.
[Is] ISSN:1557-9808
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Because of the increasing prevalence of end-stage renal disease, more percutaneous interventions are being performed. They serve an important role, allowing for restoration of access function, which is achieved with high level of technical success. However, complications are inevitable during any types of procedure, and percutaneous dialysis interventions are no exception. To provide safe and effective care these patients need, anyone performing endovascular dialysis interventions needs to understand the possible complications, how they can be avoided, and how they can be addressed if they are to occur. Topics in this article include complications seen while intervening on the thrombosed access, complications of angioplasty, potentially devastating complications of central venous interventions, and complications of dialysis catheter placement. Further, patients with end-stage renal disease are generally sicker than the average patient, usually afflicted by multiple comorbidities and are therefore more complicated from a medical perspective. This places them at higher risk for acute cardiopulmonary decompensation or arrest than any other interventional radiology patient subset. As result, we also briefly review general medical complications in this population.
[Mh] Termos MeSH primário: Derivação Arteriovenosa Cirúrgica/efeitos adversos
Implante de Prótese Vascular/efeitos adversos
Obstrução do Cateter/etiologia
Cateterismo Venoso Central/efeitos adversos
Procedimentos Endovasculares
Oclusão de Enxerto Vascular/terapia
Falência Renal Crônica/terapia
Diálise Renal
Trombose Venosa Profunda de Membros Superiores/terapia
[Mh] Termos MeSH secundário: Procedimentos Endovasculares/efeitos adversos
Oclusão de Enxerto Vascular/diagnóstico por imagem
Oclusão de Enxerto Vascular/etiologia
Seres Humanos
Falência Renal Crônica/diagnóstico
Flebografia
Radiografia Intervencionista
Fatores de Risco
Resultado do Tratamento
Trombose Venosa Profunda de Membros Superiores/diagnóstico por imagem
Trombose Venosa Profunda de Membros Superiores/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170724
[Lr] Data última revisão:
170724
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170311
[St] Status:MEDLINE


  10 / 296 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28279409
[Au] Autor:Horikawa M; Quencer KB
[Ad] Endereço:Dotter Interventional Institute, Oregon Health and Science University, Portland, OR.
[Ti] Título:Central Venous Interventions.
[So] Source:Tech Vasc Interv Radiol;20(1):48-57, 2017 Mar.
[Is] ISSN:1557-9808
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Central venous stenosis or occlusion is a common and vexing problem in patients undergoing hemodialysis. Typical presenting symptoms include arm swelling and prolonged bleeding after hemodialysis. Despite multiple treatment approaches, these stenoses tend to recur and progress over time. A thorough preprocedure evaluation, methodical procedural approach and awareness of potential complications are all essential to try to preserve vascular access and improve patients' quality of life.
[Mh] Termos MeSH primário: Implante de Prótese Vascular
Obstrução do Cateter/etiologia
Cateterismo Venoso Central/efeitos adversos
Procedimentos Endovasculares
Falência Renal Crônica/terapia
Diálise Renal
Trombose Venosa Profunda de Membros Superiores/terapia
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Implante de Prótese Vascular/efeitos adversos
Angiografia por Tomografia Computadorizada
Progressão da Doença
Procedimentos Endovasculares/efeitos adversos
Feminino
Seres Humanos
Falência Renal Crônica/diagnóstico
Ligadura
Masculino
Meia-Idade
Flebografia/métodos
Qualidade de Vida
Recidiva
Fatores de Risco
Resultado do Tratamento
Trombose Venosa Profunda de Membros Superiores/diagnóstico por imagem
Trombose Venosa Profunda de Membros Superiores/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170724
[Lr] Data última revisão:
170724
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170311
[St] Status:MEDLINE



página 1 de 30 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde